Review



mouse il 6 elisa kit  (Sino Biological)


Bioz Verified Symbol Sino Biological is a verified supplier
Bioz Manufacturer Symbol Sino Biological manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Sino Biological mouse il 6 elisa kit
    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Mouse Il 6 Elisa Kit, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+6/Mouse+IL6ST+%2F+gp130+%2F+CD130+ELISA+Pair+Set/pmc13752232-299-7-14
    Average 94 stars, based on 1 article reviews
    mouse il 6 elisa kit - by Bioz Stars, 2026-11
    94/100 stars

    Images

    1) Product Images from "Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation"

    Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

    Journal: Exploration

    doi: 10.1002/exp2.70249

    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, Il‐6, Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Figure Legend Snippet: NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, Il‐6, Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Techniques Used: In Vitro, Inhibition, Labeling, Analysis, Expressing, Fluorescence, Cell Culture, Exosomes, Quantitative RT-PCR, Flow Cytometry, Western Blot, Derivative Assay

    NANP modulates the miRNA content in exosomes through the upregulation of SMPD3. (A) Volcano plot showing the differential expression analysis of miRNAs between MSCs‐exo and NAD + ‐loaded MSCs‐exo. (B) GO analysis of significantly enriched genes in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (C) Heatmap illustrating the upregulation of miRNAs in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (D) qRT‐PCR analysis of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p expression in exosomes from MSCs treated with or without NANP. (E) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, followed by transfection with siRNA‐ctrl or a combination of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p mimics (miR‐30a/146a/146b) for an additional 24 h. The mRNA expressions of the Tnf‐a , Il‐6 , Nos2 , and Il‐10 genes were detected using qRT‐PCR ( n = 3). (F) The mRNA expressions of Hnrnpa2b1 , Smpd3 , Anxa2 , Ybx1 , and Syncrip of MSCs with or without 25 µM NANP treatment for 48 h ( n = 3). (G) Protein levels of SMPD3 and YBX1 in MSCs with or without NANP (25 µM, 48 h) treatment. (H) Western blot and qRT‐PCR showing that MSCs with shRNA‐mediated SMPD3 knockdown (MSCs‐sh‐Smpd3) fail to respond to NANP‐induced SMPD3 upregulation. (I) Western blot analysis of the exosomal markers TSG101 and CD81 detected in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 cells. (J) The expression of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 in the presence or absence of NANP, measured by qRT‐PCR ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Figure Legend Snippet: NANP modulates the miRNA content in exosomes through the upregulation of SMPD3. (A) Volcano plot showing the differential expression analysis of miRNAs between MSCs‐exo and NAD + ‐loaded MSCs‐exo. (B) GO analysis of significantly enriched genes in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (C) Heatmap illustrating the upregulation of miRNAs in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (D) qRT‐PCR analysis of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p expression in exosomes from MSCs treated with or without NANP. (E) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, followed by transfection with siRNA‐ctrl or a combination of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p mimics (miR‐30a/146a/146b) for an additional 24 h. The mRNA expressions of the Tnf‐a , Il‐6 , Nos2 , and Il‐10 genes were detected using qRT‐PCR ( n = 3). (F) The mRNA expressions of Hnrnpa2b1 , Smpd3 , Anxa2 , Ybx1 , and Syncrip of MSCs with or without 25 µM NANP treatment for 48 h ( n = 3). (G) Protein levels of SMPD3 and YBX1 in MSCs with or without NANP (25 µM, 48 h) treatment. (H) Western blot and qRT‐PCR showing that MSCs with shRNA‐mediated SMPD3 knockdown (MSCs‐sh‐Smpd3) fail to respond to NANP‐induced SMPD3 upregulation. (I) Western blot analysis of the exosomal markers TSG101 and CD81 detected in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 cells. (J) The expression of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 in the presence or absence of NANP, measured by qRT‐PCR ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Techniques Used: Exosomes, Quantitative Proteomics, Analysis, Quantitative RT-PCR, Expressing, Transfection, Western Blot, shRNA, Knockdown, Derivative Assay, Cell Surface Receptor Assay, Gene Expression

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Pioneer: a synthetic human antibody phage display library for rapid therapeutic lead generation
    Article Snippet: .. For panning on ELISA plates with directly adsorbed antigens, OX40 (Sino Biological, 10481-H08H), IL-6 (Sino Biological, 10395-HNAE), GFP (produced in-house), sarilumab (Sanofi), or TIGIT (Acro Biosystems, TIT-H5254) was coated at 5 μg/mL (TIGIT) or 10 μg/mL (all other antigens) in PBS overnight at 4°C in 96-well MaxiSorp plates (Thermo Fisher Scientific). ..

    Article Title: Associations Between Nutrient Intake and Vascular Inflammation Among Healthy Adults Living in Rural and Peri-Urban Particulate Matter 2.5-Affected Areas: An Exploratory Study.
    Article Snippet: The serum levels of key vascular inflammatory biomarkers—intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and interleukin-6 (IL6)—were determined using enzyme-linked immunosorbent assay (ELISA) with colorimetric detection. .. Commercial ELISA pair sets were employed for each target analyte, specifically: Human ICAM-1 (Cat. No. SEKA10346), VCAM-1 (Cat. No. SEK10113), and IL-6 (Cat. No. SEKB10395), all supplied by Sino Biological Inc. (Wayne, PA, USA). .. Absorbance values were read at a wavelength of 450 nm using a microplate reader (BMG Labtech, Ortenberg, Germany).

    Article Title: Associations Between Nutrient Intake and Vascular Inflammation Among Healthy Adults Living in Rural and Peri-Urban Particulate Matter 2.5-Affected Areas: An Exploratory Study
    Article Snippet: The serum levels of key vascular inflammatory biomarkers—intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and interleukin-6 (IL-6)—were determined using enzyme-linked immunosorbent assay (ELISA) with colorimetric detection. .. Commercial ELISA pair sets were employed for each target analyte, specifically: Human ICAM-1 (Cat. No. SEKA10346), VCAM-1 (Cat. No. SEK10113 ), and IL-6 (Cat. No. SEKB10395), all supplied by Sino Biological Inc. (Wayne, PA, USA). .. Absorbance values were read at a wavelength of 450 nm using a microplate reader (BMG Labtech, Ortenberg, Germany).

    Article Title: The CSF1R/PI3Kδ dual inhibitor JMC14 suppresses angiogenesis in clear cell renal cell carcinoma by reprogramming the tumor microenvironment
    Article Snippet: Cytokine levels in CM derived from THP-1 culture were measured by Shanghai 8 Universal Biotech Co., Ltd. (Shanghai, China) using Luminex LX-MultiDTX-27. .. The levels of IL-6 (Sino Biological, Beijing, China, No. KIT10395A), IL-8 or VEGF 11 (Absin, Shanghai, China, No. abs510004 or abs510008) in cell culture medium were 12 measured using the ELISA Kits. ..

    Article Title: Endothelium-specific endoglin triggers astrocyte reactivity via extracellular vesicles in a mouse model of Alzheimer’s disease
    Article Snippet: .. HCMEC/D3 cells were treated with LPS (Sigma-Aldrich, #L2630, USA) at a concentration of 100 ng/ml, IL-6 (SinoBiological, #GMP-10395-HNAE, China) at 10 ng/mL or TNF-α (SinoBiological, #10602-HNAE, China) at 50 ng/mL for 24 h for qRT-PCR and ELISA test. .. Mice primary astrocytes were treated with recombinant human ENG protein (SinoBiological, #10149-H02H, China) at 50 ng/mL or SB431542 (MedChemExpress, #HY-10431, USA) at 10 μM for 24 h for qRT-PCR or Western blotting.

    Produced:

    Article Title: Pioneer: a synthetic human antibody phage display library for rapid therapeutic lead generation
    Article Snippet: .. For panning on ELISA plates with directly adsorbed antigens, OX40 (Sino Biological, 10481-H08H), IL-6 (Sino Biological, 10395-HNAE), GFP (produced in-house), sarilumab (Sanofi), or TIGIT (Acro Biosystems, TIT-H5254) was coated at 5 μg/mL (TIGIT) or 10 μg/mL (all other antigens) in PBS overnight at 4°C in 96-well MaxiSorp plates (Thermo Fisher Scientific). ..

    Blocking Assay:

    Article Title: Thermo-sensitive polyethylene glycol-based hydrogel for controlled peptide decoy release: a novel therapy for bladder fibrosis in male mice with partial outlet obstruction
    Article Snippet: A novel thermo-sensitive polyethylene glycol (PEG)-based hydrogel formulation combining KCF18—a peptide decoy that inhibits receptor binding of tumor necrosis factor-α, interleukin-1β, and interleukin-6—was developed to enable controlled release of KCF18 for the treatment of bladder fibrosis resulting from partial bladder outlet obstruction (BOO).. The hydrogel, composed of methyl PEG–poly(lactic-co-glycolic acid) (mPEG–PLGA, diblock copolymer) and PLGA–PEG–PLGA (triblock copolymer) at a 5:5 wt ratio, was mixed with KCF18 (1.5 mg/kg) to produce a 20 % KCF-hydrogel solution (100 μL).. Pharmacokinetic analysis revealed a peak plasma KCF18 concentration on Day 1, sustained through Day 2, with an estimated half-life of 3.5 days.

    Incubation:

    Article Title: Thermo-sensitive polyethylene glycol-based hydrogel for controlled peptide decoy release: a novel therapy for bladder fibrosis in male mice with partial outlet obstruction
    Article Snippet: A novel thermo-sensitive polyethylene glycol (PEG)-based hydrogel formulation combining KCF18—a peptide decoy that inhibits receptor binding of tumor necrosis factor-α, interleukin-1β, and interleukin-6—was developed to enable controlled release of KCF18 for the treatment of bladder fibrosis resulting from partial bladder outlet obstruction (BOO).. The hydrogel, composed of methyl PEG–poly(lactic-co-glycolic acid) (mPEG–PLGA, diblock copolymer) and PLGA–PEG–PLGA (triblock copolymer) at a 5:5 wt ratio, was mixed with KCF18 (1.5 mg/kg) to produce a 20 % KCF-hydrogel solution (100 μL).. Pharmacokinetic analysis revealed a peak plasma KCF18 concentration on Day 1, sustained through Day 2, with an estimated half-life of 3.5 days.

    other:

    Article Title: Elevated SNHG15 empowers keratinocytes hyperproliferation through activation of STAT3/Cyclin D1 axis in psoriasis
    Article Snippet: IL-6 (10395-HNAE), IL-1 β (10139-HNAE), TNF- α (10602-HNAE), IL-22 (13059-HNAE), and IL-17A (12047-HNAE) were acquired from Sino Biological Inc. (Beijing, China).

    Cell Culture:

    Article Title: The CSF1R/PI3Kδ dual inhibitor JMC14 suppresses angiogenesis in clear cell renal cell carcinoma by reprogramming the tumor microenvironment
    Article Snippet: Cytokine levels in CM derived from THP-1 culture were measured by Shanghai 8 Universal Biotech Co., Ltd. (Shanghai, China) using Luminex LX-MultiDTX-27. .. The levels of IL-6 (Sino Biological, Beijing, China, No. KIT10395A), IL-8 or VEGF 11 (Absin, Shanghai, China, No. abs510004 or abs510008) in cell culture medium were 12 measured using the ELISA Kits. ..

    Concentration Assay:

    Article Title: Endothelium-specific endoglin triggers astrocyte reactivity via extracellular vesicles in a mouse model of Alzheimer’s disease
    Article Snippet: .. HCMEC/D3 cells were treated with LPS (Sigma-Aldrich, #L2630, USA) at a concentration of 100 ng/ml, IL-6 (SinoBiological, #GMP-10395-HNAE, China) at 10 ng/mL or TNF-α (SinoBiological, #10602-HNAE, China) at 50 ng/mL for 24 h for qRT-PCR and ELISA test. .. Mice primary astrocytes were treated with recombinant human ENG protein (SinoBiological, #10149-H02H, China) at 50 ng/mL or SB431542 (MedChemExpress, #HY-10431, USA) at 10 μM for 24 h for qRT-PCR or Western blotting.

    Quantitative RT-PCR:

    Article Title: Endothelium-specific endoglin triggers astrocyte reactivity via extracellular vesicles in a mouse model of Alzheimer’s disease
    Article Snippet: .. HCMEC/D3 cells were treated with LPS (Sigma-Aldrich, #L2630, USA) at a concentration of 100 ng/ml, IL-6 (SinoBiological, #GMP-10395-HNAE, China) at 10 ng/mL or TNF-α (SinoBiological, #10602-HNAE, China) at 50 ng/mL for 24 h for qRT-PCR and ELISA test. .. Mice primary astrocytes were treated with recombinant human ENG protein (SinoBiological, #10149-H02H, China) at 50 ng/mL or SB431542 (MedChemExpress, #HY-10431, USA) at 10 μM for 24 h for qRT-PCR or Western blotting.



    Similar Products

    99
    NSJ Bioreagents il-6 antibody
    Il 6 Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+6/IL-6+Antibody/custom%40v2346%4042774904
    Average 99 stars, based on 1 article reviews
    il-6 antibody - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    94
    MedChemExpress il6
    Il6, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+6/IL-6%2C+Mouse/pm42454709-255-22-23
    Average 94 stars, based on 1 article reviews
    il6 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    Krishgen Biosystems interleukin 6 il 6
    Effect of HESP on brain (A) TNF‐α; (B) <t>IL‐6;</t> (C) IL‐1β and (D) NF‐κB levels of animals exposed to CUMS. Values are presented as mean ± SD ( n = 8) and analyzed by one‐way ANOVA followed by Tukey's multiple comparison test. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05. CUMS, chronic unpredictable mild stress; FXT, fluoxetine; HESP, hesperidin; IL‐6, <t>interleukin‐6;</t> IL‐1β, interleukin‐1 beta; LY294002, phosphoinositide 3‐kinase inhibitor; NF‐κB, nuclear factor‐kappa B; ns, non‐significant; SD, standard deviation; TNF‐α, tumor necrosis factor‐alpha.
    Interleukin 6 Il 6, supplied by Krishgen Biosystems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+6/GENLISA+Mouse+Interleukin-6+(IL6+%2F+IL-6)+ELISA/pmc13770491-47-32-34
    Average 95 stars, based on 1 article reviews
    interleukin 6 il 6 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    96
    R&D Systems il 6
    Circulating inflammatory markers before (BL) and after (POST) 8 h of simulated indoor overheating at 31°C and 45% relative humidity without (control; CON) or with a ceiling fan delivering ∼1.5 m s −1 (FAN). Absolute concentrations and individual changes are shown for tumour necrosis factor‐α (TNF‐α; a,b), interleukin‐6 <t>(IL‐6;</t> c,d) and C‐reactive protein (CRP; e,f). Circles represent CON and squares FAN. Small symbols and connecting lines represent individual participant responses. In panels a, c and e, large symbols and error bars represent the group mean and SD. In panels b, d and f, large symbols and error bars represent the mean change from baseline and 95% confidence interval. P ‐values in panels b, d and f represent baseline‐adjusted between‐condition contrasts derived from linear mixed‐effects models, with the Holm procedure applied across FAN versus CON biomarker comparisons.
    Il 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+6/Human+IL-6+DuoSet+ELISA/pmc13769003-110-21-11
    Average 96 stars, based on 1 article reviews
    il 6 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Elabscience Biotechnology il 6
    Gastrodin attenuates neuronal pathology and suppresses oxidative stress and neuroinflammation in the ischemic penumbra via the PI3K/Akt pathway. A Representative hematoxylin-eosin (HE, upper panel) and Nissl staining (lower panel) of the ischemic penumbra in each group. Black arrows indicate intact neurons with abundant Nissl bodies; red arrows indicate damaged neurons with nuclear pyknosis and Nissl body dissolution. B Schematic workflow of brain tissue collection and ELISA detection for oxidative stress and inflammatory markers. C - E Quantification of oxidative stress indicators in brain tissue homogenates: N = 6 rats/group. C malondialdehyde (MDA) content, D glutathione (GSH) level, and E superoxide dismutase (SOD) activity. F - G Quantification of pro-inflammatory cytokines ( F ) TNF-α and ( G ) <t>IL-6</t> in brain tissue homogenates. Data are presented as mean ± SEM. *** P < 0.001, **** P < 0.0001 vs. Sham; # P < 0.05, ## P < 0.01, ### P < 0.001 vs. PSH + PBS; ++ P < 0.01, +++ P < 0.001 vs. PSH + Gas-H group. Statistical comparisons were performed by one-way ANOVA followed by Tukey’s post hoc test
    Il 6, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+6/Rat+IL-6+(Interleukin+6)+ELISA+Kit/pmc13759594-53-39-40
    Average 96 stars, based on 1 article reviews
    il 6 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology anti interleukin 6
    Gastrodin attenuates neuronal pathology and suppresses oxidative stress and neuroinflammation in the ischemic penumbra via the PI3K/Akt pathway. A Representative hematoxylin-eosin (HE, upper panel) and Nissl staining (lower panel) of the ischemic penumbra in each group. Black arrows indicate intact neurons with abundant Nissl bodies; red arrows indicate damaged neurons with nuclear pyknosis and Nissl body dissolution. B Schematic workflow of brain tissue collection and ELISA detection for oxidative stress and inflammatory markers. C - E Quantification of oxidative stress indicators in brain tissue homogenates: N = 6 rats/group. C malondialdehyde (MDA) content, D glutathione (GSH) level, and E superoxide dismutase (SOD) activity. F - G Quantification of pro-inflammatory cytokines ( F ) TNF-α and ( G ) <t>IL-6</t> in brain tissue homogenates. Data are presented as mean ± SEM. *** P < 0.001, **** P < 0.0001 vs. Sham; # P < 0.05, ## P < 0.01, ### P < 0.001 vs. PSH + PBS; ++ P < 0.01, +++ P < 0.001 vs. PSH + Gas-H group. Statistical comparisons were performed by one-way ANOVA followed by Tukey’s post hoc test
    Anti Interleukin 6, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+6/IL-6/pm42784913-80-17-19
    Average 96 stars, based on 1 article reviews
    anti interleukin 6 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    93
    Proteintech human elisa kits
    The expression of fibroblast activation markers and cell growth and migration. ( A ) SV80 were transfected with empty (Control), wild type FGFBP2 (WT1, WT2, WT3) and FGFBP2-Mutation (MUT1, MUT2, MUT3) plasmid and verified by qPCR. ( B , C ) Western blot images and quantifications of FGFBP2 protein expression in control, wild type and mutant groups. ( D-H ) Expression levels of ( D ) α-SMA, ( E ) TGF-β, ( F ) IL-6, ( G ) TNF-α, ( H ) IL-1β were verified by qPCR in FGFBP2 control, wild type (WT), and mutant (MUT) groups; ( I ) IL-6 levels in <t>conditioned</t> medium derived from FGFBP2 wild type and mutant cells were quantified by <t>ELISA.</t> ( J ) Viable cell numbers of FGFBP2 wild-type (FGFBP2 WT ) and mutant (FGFBP2 MUT ) cells assessed by MTT assay. ( K ) Cell migration of FGFBP2 wild type and mutated cells. ( A-C , I-K ) Two-tailed unpaired Student’s t-tests were used for two-group comparisons. ( D-H ) One-way ANOVA followed by Tukey’s post hoc test was used for multiple-group comparisons. Data are presented as mean ± SD from three independent biological replicates, using three independent stable clones.* p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant
    Human Elisa Kits, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+6/Human+IL-6+ELISA+Kit/pmc13757086-65-12-15
    Average 93 stars, based on 1 article reviews
    human elisa kits - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Sino Biological mouse il 6 elisa kit
    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Mouse Il 6 Elisa Kit, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+6/Mouse+IL6ST+%2F+gp130+%2F+CD130+ELISA+Pair+Set/pmc13752232-299-7-14
    Average 94 stars, based on 1 article reviews
    mouse il 6 elisa kit - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    Effect of HESP on brain (A) TNF‐α; (B) IL‐6; (C) IL‐1β and (D) NF‐κB levels of animals exposed to CUMS. Values are presented as mean ± SD ( n = 8) and analyzed by one‐way ANOVA followed by Tukey's multiple comparison test. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05. CUMS, chronic unpredictable mild stress; FXT, fluoxetine; HESP, hesperidin; IL‐6, interleukin‐6; IL‐1β, interleukin‐1 beta; LY294002, phosphoinositide 3‐kinase inhibitor; NF‐κB, nuclear factor‐kappa B; ns, non‐significant; SD, standard deviation; TNF‐α, tumor necrosis factor‐alpha.

    Journal: Journal of Biochemical and Molecular Toxicology

    Article Title: Hesperidin Attenuates Chronic Stress Induced Depressive‐Like Behavior in Mice: Pharmacological and Computational Evidence for PI3K Involvement

    doi: 10.1002/jbt.71176

    Figure Lengend Snippet: Effect of HESP on brain (A) TNF‐α; (B) IL‐6; (C) IL‐1β and (D) NF‐κB levels of animals exposed to CUMS. Values are presented as mean ± SD ( n = 8) and analyzed by one‐way ANOVA followed by Tukey's multiple comparison test. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05. CUMS, chronic unpredictable mild stress; FXT, fluoxetine; HESP, hesperidin; IL‐6, interleukin‐6; IL‐1β, interleukin‐1 beta; LY294002, phosphoinositide 3‐kinase inhibitor; NF‐κB, nuclear factor‐kappa B; ns, non‐significant; SD, standard deviation; TNF‐α, tumor necrosis factor‐alpha.

    Article Snippet: Enzyme‐linked immunosorbent assay (ELISA) kits used for estimation of inflammatory markers including nuclear factor‐kappa B (NF‐κB) (Kinesis Dx, India, Catalogue no. K02‐2879), interleukin‐1 beta (IL‐1β) (Krishgen Biosystems, Mumbai, India, Catalogue no. KB2083), interleukin‐6 (IL‐6) (Krishgen Biosystems, India, Catalogue no. KB2068), and tumor necrosis factor‐alpha (TNF‐α) (BT Labs, Shanghai, China, Catalogue no. E0117Mo) were obtained commercially.

    Techniques: Comparison, Standard Deviation

    Circulating inflammatory markers before (BL) and after (POST) 8 h of simulated indoor overheating at 31°C and 45% relative humidity without (control; CON) or with a ceiling fan delivering ∼1.5 m s −1 (FAN). Absolute concentrations and individual changes are shown for tumour necrosis factor‐α (TNF‐α; a,b), interleukin‐6 (IL‐6; c,d) and C‐reactive protein (CRP; e,f). Circles represent CON and squares FAN. Small symbols and connecting lines represent individual participant responses. In panels a, c and e, large symbols and error bars represent the group mean and SD. In panels b, d and f, large symbols and error bars represent the mean change from baseline and 95% confidence interval. P ‐values in panels b, d and f represent baseline‐adjusted between‐condition contrasts derived from linear mixed‐effects models, with the Holm procedure applied across FAN versus CON biomarker comparisons.

    Journal: Experimental Physiology

    Article Title: Does ceiling‐fan use modify circulating markers of heat‐related stress in bed‐resting older adults?

    doi: 10.1113/EP094380

    Figure Lengend Snippet: Circulating inflammatory markers before (BL) and after (POST) 8 h of simulated indoor overheating at 31°C and 45% relative humidity without (control; CON) or with a ceiling fan delivering ∼1.5 m s −1 (FAN). Absolute concentrations and individual changes are shown for tumour necrosis factor‐α (TNF‐α; a,b), interleukin‐6 (IL‐6; c,d) and C‐reactive protein (CRP; e,f). Circles represent CON and squares FAN. Small symbols and connecting lines represent individual participant responses. In panels a, c and e, large symbols and error bars represent the group mean and SD. In panels b, d and f, large symbols and error bars represent the mean change from baseline and 95% confidence interval. P ‐values in panels b, d and f represent baseline‐adjusted between‐condition contrasts derived from linear mixed‐effects models, with the Holm procedure applied across FAN versus CON biomarker comparisons.

    Article Snippet: Serum samples were analysed in duplicate using commercially available sandwich ELISAs (R&D Systems, Minneapolis, MN, USA) for IFABP (DY3078), sCD14 (DY383), IL‐6 (DY206), TNF‐α (DY210), CRP (DY1707), NGAL (DY1757) and KIM‐1 (DY1750).

    Techniques: Control, Derivative Assay, Biomarker Discovery

    Gastrodin attenuates neuronal pathology and suppresses oxidative stress and neuroinflammation in the ischemic penumbra via the PI3K/Akt pathway. A Representative hematoxylin-eosin (HE, upper panel) and Nissl staining (lower panel) of the ischemic penumbra in each group. Black arrows indicate intact neurons with abundant Nissl bodies; red arrows indicate damaged neurons with nuclear pyknosis and Nissl body dissolution. B Schematic workflow of brain tissue collection and ELISA detection for oxidative stress and inflammatory markers. C - E Quantification of oxidative stress indicators in brain tissue homogenates: N = 6 rats/group. C malondialdehyde (MDA) content, D glutathione (GSH) level, and E superoxide dismutase (SOD) activity. F - G Quantification of pro-inflammatory cytokines ( F ) TNF-α and ( G ) IL-6 in brain tissue homogenates. Data are presented as mean ± SEM. *** P < 0.001, **** P < 0.0001 vs. Sham; # P < 0.05, ## P < 0.01, ### P < 0.001 vs. PSH + PBS; ++ P < 0.01, +++ P < 0.001 vs. PSH + Gas-H group. Statistical comparisons were performed by one-way ANOVA followed by Tukey’s post hoc test

    Journal: Neurochemical Research

    Article Title: Gastrodin Alleviates Post-Stroke Headache and Neuronal Injury via Activating the PI3K/Akt Pathway

    doi: 10.1007/s11064-026-04932-2

    Figure Lengend Snippet: Gastrodin attenuates neuronal pathology and suppresses oxidative stress and neuroinflammation in the ischemic penumbra via the PI3K/Akt pathway. A Representative hematoxylin-eosin (HE, upper panel) and Nissl staining (lower panel) of the ischemic penumbra in each group. Black arrows indicate intact neurons with abundant Nissl bodies; red arrows indicate damaged neurons with nuclear pyknosis and Nissl body dissolution. B Schematic workflow of brain tissue collection and ELISA detection for oxidative stress and inflammatory markers. C - E Quantification of oxidative stress indicators in brain tissue homogenates: N = 6 rats/group. C malondialdehyde (MDA) content, D glutathione (GSH) level, and E superoxide dismutase (SOD) activity. F - G Quantification of pro-inflammatory cytokines ( F ) TNF-α and ( G ) IL-6 in brain tissue homogenates. Data are presented as mean ± SEM. *** P < 0.001, **** P < 0.0001 vs. Sham; # P < 0.05, ## P < 0.01, ### P < 0.001 vs. PSH + PBS; ++ P < 0.01, +++ P < 0.001 vs. PSH + Gas-H group. Statistical comparisons were performed by one-way ANOVA followed by Tukey’s post hoc test

    Article Snippet: Reagents and antibodies used in this study were obtained from the indicated sources: Monofilament nylon suture (Beijing Xinnong, 3043-A4); gastrodin (Aladdin, G299059); ELISA kits for rat malondialdehyde (Elabscience, E-BC-K025-M), superoxide dismutase (Elabscience, E-BC-K020-M), glutathione (Elabscience, E-EL-0026), TNF-α (Elabscience, E-EL-R2856), IL-6 (Elabscience, E-EL-R0015), human PI3K (ELK biotechnology, ELK9879), and human Akt (ELK biotechnology, ELK0371); PI3K inhibitor LY294002 (MedChemExpress, USA); TTC staining solution (biosharp, BL1215A); Nissl staining solution (biosharp, BL1039A); hematoxylin-eosin staining solution (Hubei Pumei Biotechnology, PMK0270); Trizol (Invitrogen, 15596018); reverse transcription kit (Vazyme, R233-01); qPCR kit (Vazyme, Q712-02); RIPA lysis buffer (Beyotime, Shanghai); primer synthesis (Sangon, Shanghai); Primary antibodies against c-Fos (Synaptic Systems Antibody, Cat# 226017, RRID: AB_2864765; IF 1:200), caspase-3 (Proteintech, Cat# 19677-1-AP, RRID: AB_10733244; IF 1:150, WB 1:800), Bcl-2 (Proteintech, Cat# 68103-1-Ig, RRID: AB_2923635; IF 1:200; WB 1:1000), PI3K (Proteintech, Cat# 60225-1-IG, RRID: AB_11042594; WB 1:800), Akt (Proteintech, Cat# 60203-2-Ig, RRID: AB_10912803; WB 1:1000), p-Akt (Proteintech, Cat# 66444-1-Ig, RRID: AB_2782958; WB 1:1000), CGRP (ABclonal, Cat# A5542, RRID: AB_2766323; WB 1:800), substance P (Invitrogen, Cat# PA5-106934, RRID: AB_2854598; WB 1:1000), Iba1(Wako, Cat# 019–19741, RRID: AB_839504; IF 1:300), GFAP (Cell signaling Technology, Cat# 3670 S, RRID: AB_561049; IF 1:200), and GAPDH (Proteintech, Cat# 60004-1-Ig, RRID: AB_2107436; WB 1:3000); Donkey Anti-Rat IgG H&L (Alexa Fluor 555) preadsorbed (Abcam, Cat# ab150154, RRID: AB_2813834; dilution ratio 1:350), Alexa Fluor 488- and 546-conjugated secondary antibodies (Invitrogen, Cat# A-21202, RRID: AB_141607; Cat# A10040, RRID: AB_2534016; dilution ratio 1:200) for Immunofluorescence; IRDye 800CW Goat anti- Mouse and Goat Anti-Rabbit IgG Secondary Antibody for western blot (LI-COR, Cat# 926–32210, RRID: AB_621842; Cat# 926–32211, RRID: AB_621843; dilution ratio 1:10000).

    Techniques: Pathology, H&E Stain, Nissl Staining, Dissolution, Tissue, Enzyme-linked Immunosorbent Assay, Activity Assay

    Journal: Neurochemical Research

    Article Title: Gastrodin Alleviates Post-Stroke Headache and Neuronal Injury via Activating the PI3K/Akt Pathway

    doi: 10.1007/s11064-026-04932-2

    Figure Lengend Snippet:

    Article Snippet: Reagents and antibodies used in this study were obtained from the indicated sources: Monofilament nylon suture (Beijing Xinnong, 3043-A4); gastrodin (Aladdin, G299059); ELISA kits for rat malondialdehyde (Elabscience, E-BC-K025-M), superoxide dismutase (Elabscience, E-BC-K020-M), glutathione (Elabscience, E-EL-0026), TNF-α (Elabscience, E-EL-R2856), IL-6 (Elabscience, E-EL-R0015), human PI3K (ELK biotechnology, ELK9879), and human Akt (ELK biotechnology, ELK0371); PI3K inhibitor LY294002 (MedChemExpress, USA); TTC staining solution (biosharp, BL1215A); Nissl staining solution (biosharp, BL1039A); hematoxylin-eosin staining solution (Hubei Pumei Biotechnology, PMK0270); Trizol (Invitrogen, 15596018); reverse transcription kit (Vazyme, R233-01); qPCR kit (Vazyme, Q712-02); RIPA lysis buffer (Beyotime, Shanghai); primer synthesis (Sangon, Shanghai); Primary antibodies against c-Fos (Synaptic Systems Antibody, Cat# 226017, RRID: AB_2864765; IF 1:200), caspase-3 (Proteintech, Cat# 19677-1-AP, RRID: AB_10733244; IF 1:150, WB 1:800), Bcl-2 (Proteintech, Cat# 68103-1-Ig, RRID: AB_2923635; IF 1:200; WB 1:1000), PI3K (Proteintech, Cat# 60225-1-IG, RRID: AB_11042594; WB 1:800), Akt (Proteintech, Cat# 60203-2-Ig, RRID: AB_10912803; WB 1:1000), p-Akt (Proteintech, Cat# 66444-1-Ig, RRID: AB_2782958; WB 1:1000), CGRP (ABclonal, Cat# A5542, RRID: AB_2766323; WB 1:800), substance P (Invitrogen, Cat# PA5-106934, RRID: AB_2854598; WB 1:1000), Iba1(Wako, Cat# 019–19741, RRID: AB_839504; IF 1:300), GFAP (Cell signaling Technology, Cat# 3670 S, RRID: AB_561049; IF 1:200), and GAPDH (Proteintech, Cat# 60004-1-Ig, RRID: AB_2107436; WB 1:3000); Donkey Anti-Rat IgG H&L (Alexa Fluor 555) preadsorbed (Abcam, Cat# ab150154, RRID: AB_2813834; dilution ratio 1:350), Alexa Fluor 488- and 546-conjugated secondary antibodies (Invitrogen, Cat# A-21202, RRID: AB_141607; Cat# A10040, RRID: AB_2534016; dilution ratio 1:200) for Immunofluorescence; IRDye 800CW Goat anti- Mouse and Goat Anti-Rabbit IgG Secondary Antibody for western blot (LI-COR, Cat# 926–32210, RRID: AB_621842; Cat# 926–32211, RRID: AB_621843; dilution ratio 1:10000).

    Techniques:

    The expression of fibroblast activation markers and cell growth and migration. ( A ) SV80 were transfected with empty (Control), wild type FGFBP2 (WT1, WT2, WT3) and FGFBP2-Mutation (MUT1, MUT2, MUT3) plasmid and verified by qPCR. ( B , C ) Western blot images and quantifications of FGFBP2 protein expression in control, wild type and mutant groups. ( D-H ) Expression levels of ( D ) α-SMA, ( E ) TGF-β, ( F ) IL-6, ( G ) TNF-α, ( H ) IL-1β were verified by qPCR in FGFBP2 control, wild type (WT), and mutant (MUT) groups; ( I ) IL-6 levels in conditioned medium derived from FGFBP2 wild type and mutant cells were quantified by ELISA. ( J ) Viable cell numbers of FGFBP2 wild-type (FGFBP2 WT ) and mutant (FGFBP2 MUT ) cells assessed by MTT assay. ( K ) Cell migration of FGFBP2 wild type and mutated cells. ( A-C , I-K ) Two-tailed unpaired Student’s t-tests were used for two-group comparisons. ( D-H ) One-way ANOVA followed by Tukey’s post hoc test was used for multiple-group comparisons. Data are presented as mean ± SD from three independent biological replicates, using three independent stable clones.* p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant

    Journal: Journal of Translational Medicine

    Article Title: FGFBP2 p.T186S mutation in tumor associated fibroblasts supports progression of pancreatic cancer through autocrine and paracrine mechanisms

    doi: 10.1186/s12967-026-09137-3

    Figure Lengend Snippet: The expression of fibroblast activation markers and cell growth and migration. ( A ) SV80 were transfected with empty (Control), wild type FGFBP2 (WT1, WT2, WT3) and FGFBP2-Mutation (MUT1, MUT2, MUT3) plasmid and verified by qPCR. ( B , C ) Western blot images and quantifications of FGFBP2 protein expression in control, wild type and mutant groups. ( D-H ) Expression levels of ( D ) α-SMA, ( E ) TGF-β, ( F ) IL-6, ( G ) TNF-α, ( H ) IL-1β were verified by qPCR in FGFBP2 control, wild type (WT), and mutant (MUT) groups; ( I ) IL-6 levels in conditioned medium derived from FGFBP2 wild type and mutant cells were quantified by ELISA. ( J ) Viable cell numbers of FGFBP2 wild-type (FGFBP2 WT ) and mutant (FGFBP2 MUT ) cells assessed by MTT assay. ( K ) Cell migration of FGFBP2 wild type and mutated cells. ( A-C , I-K ) Two-tailed unpaired Student’s t-tests were used for two-group comparisons. ( D-H ) One-way ANOVA followed by Tukey’s post hoc test was used for multiple-group comparisons. Data are presented as mean ± SD from three independent biological replicates, using three independent stable clones.* p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant

    Article Snippet: The concentrations of IL-6 and FGF2 in conditioned media were measured using human ELISA kits (Proteintech; Human IL-6 ELISA Kit, Cat#: KE00385; Human FGF2 ELISA Kit, Cat#: KE00129, China) according to the manufacturer’s instructions.

    Techniques: Expressing, Activation Assay, Migration, Transfection, Control, Mutagenesis, Plasmid Preparation, Western Blot, Derivative Assay, Enzyme-linked Immunosorbent Assay, MTT Assay, Two Tailed Test, Clone Assay

    Effects of MEK inhibition, IL-6R blockade, and EHF modulation on ERK1/2 signaling induced by FGFBP2 mutant fibroblast-derived conditioned medium in PANC-1 cells. ( A-C ) Western blot analysis of ERK1/2 and P-ERK1/2 in PANC-1 cells treated with conditioned medium derived from FGFBP2 wild type and mutant cells following pretreatment with DMSO or the MEK inhibitor U0126 (10 µM, 2 h). ( D , E ) ERK1/2 phosphorylation in PANC-1 cells treated with FGFBP2 wild-type or mutant conditioned medium in the presence or absence of tocilizumab(1ug/ml,1 h) was examined by immunoblotting. ( F , G ) ERK1/2 phosphorylation in PANC-1 cells transfected with siNC, siEHF, or siEHF combined with EHF overexpression plasmid (OE), followed by stimulation with FGFBP2 mutant conditioned medium, was examined by immunoblotting. ( H , I ) Western blot analysis of ERK1/2 and P-ERK1/2 in PANC-1 cells transfected with siNC or siEHF and treated with conditioned medium derived from FGFBP2 wild type and mutant cells. ( B , E , G , I ) results are presented as ratios of phosphorylated and unphosphorylated forms of the proteins; ( J ) STRING Analysis of the interaction between FGFBP2 and FGF2. ( K ) FGF2 expression levels were verified by qPCR in FGFBP2 control (Control), wild-type (WT), and mutant cells (MUT); ( L )FGF2 levels in conditioned medium derived from FGFBP2 wild type and mutant cells were quantified by ELISA. ( B , E , G , I ) Two-tailed unpaired Student’s t-tests were used for two-group comparisons. ( K ) One-way ANOVA followed by Tukey’s post hoc test was used for multiple-group comparisons. Data are presented as mean ± SD from three independent biological replicates. * p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant

    Journal: Journal of Translational Medicine

    Article Title: FGFBP2 p.T186S mutation in tumor associated fibroblasts supports progression of pancreatic cancer through autocrine and paracrine mechanisms

    doi: 10.1186/s12967-026-09137-3

    Figure Lengend Snippet: Effects of MEK inhibition, IL-6R blockade, and EHF modulation on ERK1/2 signaling induced by FGFBP2 mutant fibroblast-derived conditioned medium in PANC-1 cells. ( A-C ) Western blot analysis of ERK1/2 and P-ERK1/2 in PANC-1 cells treated with conditioned medium derived from FGFBP2 wild type and mutant cells following pretreatment with DMSO or the MEK inhibitor U0126 (10 µM, 2 h). ( D , E ) ERK1/2 phosphorylation in PANC-1 cells treated with FGFBP2 wild-type or mutant conditioned medium in the presence or absence of tocilizumab(1ug/ml,1 h) was examined by immunoblotting. ( F , G ) ERK1/2 phosphorylation in PANC-1 cells transfected with siNC, siEHF, or siEHF combined with EHF overexpression plasmid (OE), followed by stimulation with FGFBP2 mutant conditioned medium, was examined by immunoblotting. ( H , I ) Western blot analysis of ERK1/2 and P-ERK1/2 in PANC-1 cells transfected with siNC or siEHF and treated with conditioned medium derived from FGFBP2 wild type and mutant cells. ( B , E , G , I ) results are presented as ratios of phosphorylated and unphosphorylated forms of the proteins; ( J ) STRING Analysis of the interaction between FGFBP2 and FGF2. ( K ) FGF2 expression levels were verified by qPCR in FGFBP2 control (Control), wild-type (WT), and mutant cells (MUT); ( L )FGF2 levels in conditioned medium derived from FGFBP2 wild type and mutant cells were quantified by ELISA. ( B , E , G , I ) Two-tailed unpaired Student’s t-tests were used for two-group comparisons. ( K ) One-way ANOVA followed by Tukey’s post hoc test was used for multiple-group comparisons. Data are presented as mean ± SD from three independent biological replicates. * p < 0.05; ** p < 0.01; *** p < 0.001; ns, not significant

    Article Snippet: The concentrations of IL-6 and FGF2 in conditioned media were measured using human ELISA kits (Proteintech; Human IL-6 ELISA Kit, Cat#: KE00385; Human FGF2 ELISA Kit, Cat#: KE00129, China) according to the manufacturer’s instructions.

    Techniques: Inhibition, Mutagenesis, Derivative Assay, Western Blot, Analysis, Phospho-proteomics, Transfection, Over Expression, Plasmid Preparation, Expressing, Control, Enzyme-linked Immunosorbent Assay, Two Tailed Test

    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, Il‐6, Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Journal: Exploration

    Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

    doi: 10.1002/exp2.70249

    Figure Lengend Snippet: NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, Il‐6, Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Article Snippet: Serum IL‐6 levels were measured using a mouse IL‐6 ELISA kit ( SEK50135 , Sino Biological Inc.).

    Techniques: In Vitro, Inhibition, Labeling, Analysis, Expressing, Fluorescence, Cell Culture, Exosomes, Quantitative RT-PCR, Flow Cytometry, Western Blot, Derivative Assay

    NANP modulates the miRNA content in exosomes through the upregulation of SMPD3. (A) Volcano plot showing the differential expression analysis of miRNAs between MSCs‐exo and NAD + ‐loaded MSCs‐exo. (B) GO analysis of significantly enriched genes in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (C) Heatmap illustrating the upregulation of miRNAs in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (D) qRT‐PCR analysis of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p expression in exosomes from MSCs treated with or without NANP. (E) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, followed by transfection with siRNA‐ctrl or a combination of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p mimics (miR‐30a/146a/146b) for an additional 24 h. The mRNA expressions of the Tnf‐a , Il‐6 , Nos2 , and Il‐10 genes were detected using qRT‐PCR ( n = 3). (F) The mRNA expressions of Hnrnpa2b1 , Smpd3 , Anxa2 , Ybx1 , and Syncrip of MSCs with or without 25 µM NANP treatment for 48 h ( n = 3). (G) Protein levels of SMPD3 and YBX1 in MSCs with or without NANP (25 µM, 48 h) treatment. (H) Western blot and qRT‐PCR showing that MSCs with shRNA‐mediated SMPD3 knockdown (MSCs‐sh‐Smpd3) fail to respond to NANP‐induced SMPD3 upregulation. (I) Western blot analysis of the exosomal markers TSG101 and CD81 detected in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 cells. (J) The expression of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 in the presence or absence of NANP, measured by qRT‐PCR ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Journal: Exploration

    Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

    doi: 10.1002/exp2.70249

    Figure Lengend Snippet: NANP modulates the miRNA content in exosomes through the upregulation of SMPD3. (A) Volcano plot showing the differential expression analysis of miRNAs between MSCs‐exo and NAD + ‐loaded MSCs‐exo. (B) GO analysis of significantly enriched genes in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (C) Heatmap illustrating the upregulation of miRNAs in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (D) qRT‐PCR analysis of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p expression in exosomes from MSCs treated with or without NANP. (E) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, followed by transfection with siRNA‐ctrl or a combination of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p mimics (miR‐30a/146a/146b) for an additional 24 h. The mRNA expressions of the Tnf‐a , Il‐6 , Nos2 , and Il‐10 genes were detected using qRT‐PCR ( n = 3). (F) The mRNA expressions of Hnrnpa2b1 , Smpd3 , Anxa2 , Ybx1 , and Syncrip of MSCs with or without 25 µM NANP treatment for 48 h ( n = 3). (G) Protein levels of SMPD3 and YBX1 in MSCs with or without NANP (25 µM, 48 h) treatment. (H) Western blot and qRT‐PCR showing that MSCs with shRNA‐mediated SMPD3 knockdown (MSCs‐sh‐Smpd3) fail to respond to NANP‐induced SMPD3 upregulation. (I) Western blot analysis of the exosomal markers TSG101 and CD81 detected in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 cells. (J) The expression of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 in the presence or absence of NANP, measured by qRT‐PCR ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Article Snippet: Serum IL‐6 levels were measured using a mouse IL‐6 ELISA kit ( SEK50135 , Sino Biological Inc.).

    Techniques: Exosomes, Quantitative Proteomics, Analysis, Quantitative RT-PCR, Expressing, Transfection, Western Blot, shRNA, Knockdown, Derivative Assay, Cell Surface Receptor Assay, Gene Expression